Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Stock

Is Diamondback Energy Stock Underperforming the Dow?

Despite Diamondback Energy’s underperformance relative to the broader Dow over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Barchart

Is Cencora Stock Outperforming the Dow?

Due to Cencora’s strong performance relative to the broader Dow over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Barchart

Is Berkshire Hathaway Stock Outperforming the Nasdaq?

Berkshire Hathaway has outperformed the S&P 500 over the past year, and analysts are moderately optimistic about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Do Wall Street Analysts Like Take-Two Interactive Stock?

Take-Two Interactive has outpaced the broader market over the past year, and analysts are highly bullish on its future growth potential.

Barchart

Top 100 Stocks to Buy: Is DAVE Stock on the Road to Greatness?

Dave Inc. stock moved up 23 spots in Barchart’s Top 100 Stocks to Buy on Monday. Meanwhile, the S&P 500 gained 3.3%, five basis points more than DAVE, a possible sign its 2025 gains were nearing an end.

Barchart

Do Wall Street Analysts Like PG&E Corporation Stock?

Although PG&E Corporation has lagged behind the broader market over the past year, many Wall Street analysts remain reasonably optimistic about the stock’s future potential.

Barchart

Ford Motor Stock: Is Wall Street Bullish or Bearish?

Ford Motor has trailed the broader market over the past year, and analysts are skeptical about the stock’s future prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

MarketBeat Week in Review – 04/21 - 04/25

Stocks rallied this week on hopes of a thaw in the trade war, but key economic reports and upcoming earnings will determine if the rally has legs

MarketBeat

Ditch the Magnificent 7 and Grab These 2 Dividend Aristocrats Now

With the tech sector facing uncertainty, these top dividend stocks are worth a second look for investors thanks to their rock-solid history of dividend growth and strong fundamentals.

Barchart

Netflix just added an overlooked spy thriller movie — here's why you should stream it right now

"Operation Finale" just returned to the Netflix movie library, and this spy thriller is a compelling retelling of a historically important event.

Tom’s Guide

Do Wall Street Analysts Like Extra Space Storage Stock?

Extra Space Storage has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

Take-Two Interactive Software Stock Outlook: Is Wall Street Bullish or Bearish?

Take-Two Interactive Software has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.

Barchart

Lowe’s Stock Outlook: Is Wall Street Bullish or Bearish?

Although Lowe’s has lagged the broader market over the past year, analysts remain cautiously optimistic about its future prospects.

Barchart

Are Wall Street Analysts Predicting U.S. Bancorp Stock Will Climb or Sink?

U.S. Bancorp has struggled to keep up with the broader market over the past year, and analysts are cautiously optimistic about its future prospects

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

What Are Wall Street Analysts' Target Price for Amazon Stock?

While Amazon has outpaced the broader market over the past year, Wall Street analysts remain optimistic about the stock's growth potential.

MarketBeat

MarketBeat Week in Review – 01/27 - 01/31

Stocks posted slight gains for the week as investors shrugged off concerns over China's DeepSeek open-source API and the latest reading on inflation

Barchart

Pfizer Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Pfizer trailing behind the broader market over the past year, Wall Street analysts remain moderately bullish about the stock's potential.

Barchart

Is This 'Strong Buy'-Rated Warren Buffett Stock a Buy Now?

This company may be well-established, but its growth story is far from over.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Should You Buy Upstart Stock Before It Hits $100?

Upstart’s AI-powered platform is disrupting the fintech industry and has the potential to dramatically boost its stock price.

Barchart

How Is Packaging Corporation’s Stock Performance Compared to Other Consumer Cyclical Stocks?

Although Packaging Corporation has faced difficulties in keeping pace with its industry peers, Wall Street analysts continue to hold a moderately optimistic view of the stock's prospects.

Barchart

Is General Motors Stock Underperforming the Nasdaq?

Although General Motors has lagged behind the broader Nasdaq index over the past three months, analysts maintain a cautiously optimistic outlook on the stock's growth potential.

Tom’s Guide

One of my favorite dark thriller movies of 2024 is now streaming — and it's rated 91% on Rotten Tomatoes

"Heretic" is a gripping dark thriller that sees Hugh Grant play against type as a villainous recluse who traps two missionaries in his home.

Barchart

What Are Wall Street Analysts' Target Price for Revvity Stock?

Revvity has underperformed the broader market this year, but Wall Street analysts remain somewhat optimistic about the stock's future prospects.

MarketBeat

Rocket Lab is the Right Stock for the Right Time

Rocket Lab stock is up more than 40% after a strong earnings report; the rally may not be sustainable but the ongoing space race makes RKLB stock a buy

Evening Standard

Pete Waterman becomes patron of Brain Tumour Research in honour of son Paul

Waterman is backing the charity’s calls to increase national investment in brain tumour research to £35 million per year.

1 … 5 6 7 8

People

Gabriel OsorioMazilli

50 stories

Jea Yu

23 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.